tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX

Compare Vertex Pharmaceuticals (VRTX) vs. Competitors

Compare
6,568 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
$441.36
$111.36B
31.11
5.85%
17 Buy
5 Hold
0 Sell
Strong Buy
Alnylam Pharma
$359.27
$47.46B
1,494.47
44.19%
16 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$106.21
$20.66B
17.82
46.56%
9 Buy
9 Hold
1 Sell
Moderate Buy
Regeneron
$733.04
$77.98B
17.76
5.74%
17 Buy
6 Hold
0 Sell
Moderate Buy
Argenx Se
$800.01
$50.06B
37.58
21.25%
16 Buy
3 Hold
0 Sell
Strong Buy
BioNTech SE
$109.00
$25.51B
-41.43
-3.33%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRTX
Vertex Pharmaceuticals
441.36
13.47
3.15%
ALNY
Alnylam Pharma
359.27
94.28
35.58%
INCY
Incyte
106.21
32.74
44.56%
REGN
Regeneron
733.04
49.03
7.17%
ARGX
Argenx Se
800.01
152.62
23.57%
BNTX
BioNTech SE
109.00
-8.25
-7.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts